Basis of Presentation and Summary of Significant Accounting Policies (Top Revenue Customers) (Details) (Customer Concentration Risk [Member])	3 Months Ended	6 Months Ended		3 Months Ended		6 Months Ended			12 Months Ended	3 Months Ended		6 Months Ended	3 Months Ended		6 Months Ended
	Jun. 30, 2014 Exela (related party) [Member] Sales [Member]	Jun. 30, 2014 Exela (related party) [Member] Sales [Member]	Jun. 30, 2013 Merck [Member] Accounts Receivable [Member]	Jun. 30, 2014 Merck [Member] Sales [Member]	Jun. 30, 2013 Merck [Member] Sales [Member]	Jun. 30, 2014 Merck [Member] Sales [Member]	Jun. 30, 2013 Merck [Member] Sales [Member]	Jun. 30, 2013 Novartis [Member] Accounts Receivable [Member]	Dec. 31, 2013 Novartis [Member] Accounts Receivable [Member]	Jun. 30, 2014 Novartis [Member] Sales [Member]	Jun. 30, 2013 Novartis [Member] Sales [Member]	Jun. 30, 2014 Novartis [Member] Sales [Member]	Jun. 30, 2014 Arch [Member] Sales [Member]	Jun. 30, 2013 Arch [Member] Sales [Member]	Jun. 30, 2014 Arch [Member] Sales [Member]	Jun. 30, 2013 Arch [Member] Sales [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage	32.00%	30.00%	27.00%	28.00%	65.00%	25.00%	50.00%	25.00%	51.00%	12.00%	0.00%	20.00%	0.00%	0.00%	0.00%	12.00%